SCI论文
1. Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing. Arterioscler Thromb Vasc Biol. 2019 Apr 4:ATVBAHA119312399. doi: 10.1161/ATVBAHA.119.312399.
2. Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension. Eur Respir J. 2018 Dec21. pii: 1801609. doi: 10.1183/13993003.01609-2018.
3. Impact of Pituitary-Gonadal Axis Hormones on Pulmonary Arterial Hypertension in Men.Hypertension. 2018 Jul;72(1):151-158.
4. Prognostic Significance of Reduced Blood Pressure Response to Exercise in Pediatric Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2017 Dec1;196(11):1478-1481.
5. Hypermethylation of BMPR2 Promoter Occurs in the Patients with Heritable Pulmonary Arterial Hypertension and Inhibits BMPR2 Expression. Am J Respir Crit Care Med.2017 Oct 1;196(7):925-928.
6. Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension. Int J Cardiol. 2017 Feb 1;228:895-899.
7. Profiling nitric-oxide metabolites in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2016 Nov;48(5):1386-1395.
8. Profiling nitric-oxide metabolites in patients with idiopathic pulmonary arterial hypertension. Eur Respir J.2016 Nov; 48(5):1386-1395.
9. Elevated levels of circulating BMP7 predict mortality in pulmonary arterial hypertension. Chest. 2016 Aug;150(2):367-73.
10. BMPR2 mutation is a potential predisposing genetic risk factor for congenital heart disease associated pulmonary vascular disease. Int J Cardiol. 2016 May; 211: 132-136
中文论文
1. 中华医学会心血管病学分会肺血管病学组 中华心血管病杂志编辑委员会. 中国肺高血压诊断和治疗指南2018. 中华心血管病杂志, 2018,46(12) : 933-964.
2. 荆志成. 十年磨一剑. 中华心血管病杂志, 2018,46(12) : 918-920. (述评)
3. 荆志成. 我的博士学位论文. 中华心血管病杂志, 2018,46(12) : 915-917. (总编随笔)
4. 徐希奇,荆志成,第六届世界肺高血压会议:聚焦肺高血压定义与诊断分类更新. 协和医学杂志 , 2018 (3)
5. 荆志成. 我们还需要向西方学习多久:艾森曼格医师留给我们的机遇和挑战. 中华心血管病杂志, 2017,45(12) : 1005-1007. (总编随笔)
6. 伍琼, 贾镭, 荆志成, 罗松辉, 洪李锋. 曲前列尼尔治疗肺动脉高压的研究进展. 中华心血管病杂志, 2017,45(9) : 810-813.
7. 邱家勇, 荆志成, 王晓建, 毛毅敏, 肌钙蛋白I交互激酶:一个新的心肌重构的干预靶点. 中华心血管病杂志, 2017,45(9) : 818-820.
8. 叶珏, 何阳阳, 颜艺, 赵隽涵, 连天宇, 王晓建, 阎雨, 张思瑾, 杨淑慧, 荆志成. 过氧化氢诱导人肺动脉内皮细胞损伤模型的建立及其氧化应激机制. 中华心血管病杂志, 2017,45(07) : 613-618.
9. 王晓建 张宏达 荆志成. 星星之火可以燎原:肺动脉高压从传统诊疗走向精准医学的20年. 中华心血管病杂志. 2017;45(6):476-479.
10. 王利婷, 荆志成. 肺动脉高压治疗药物研究进展. 国际药学研究杂志. 2017, 44(2):127-134.
著作
1. Rich J. D., and Jing ZC (2015). Chapter 9-Therapies for PAH in the Developed and Developing World. In Benza R., Corris P., Park M., Uber P. (eds), ISHLT Monograph Series: Pulmonary Hypertension and Right Heart Failure (pp.134-151). Birmingham, AL: University of Alabama at Birmingham
2. Jiang X, Humbert M, Jing ZC (2012). Chapter 9- Idiopathic Pulmonary Arterial Hypertension and Its Prognosis in the Modern Mangement Era in Developed and Developing Countries. In Humbert M., Souza R., Simonneau G. (eds), Pulmonary Vascular Disorder. Prog Rrspir Res (pp.85-93). Basel: Karger Di RM, Jing ZC. (2012). Chapter 20- High-Altitude Pulmonary Hypertension. In Humbert M., Souza R., Simonneau G. (eds), Pulmonary Vascular Disorder. Prog Rrspir Res (pp.199-206). Basel: Karger
3. Beghetti M., Jing ZC. (2011). Chapter 5- Etilolgy and Epidemiology. In Beghetti M., Barst J. R. (eds), Pediatric Pulmonary Hypertension(pp.71-81). Paris: Elsevier Professional Education.
4. 荆志成,第二十二章:肺动脉高压。国家卫生健康委员会"十二五"规划教材·全国高等医药教材建设研究会"十二五"规划教材·专科医师核心能力提升导引丛书:《心血管内科学》(第2版),胡大一,马长生主编,人民卫生出版社,2014年9月出版。
5. 荆志成,蒋鑫. 第十四章:老年肺高血压。《老年心血管病学》,刘梅林主编,胡大一主审,中华医学电子音像出版社,2013年9月第一次印刷。